Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.24.2.u1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Income Statement [Abstract]        
Net revenues
Gross Profit
Operating expenses:        
Marketing expenses 8 100 346 284
Stock based compensation 37,500 37,500 75,000 75,000
Research and development 240,429 219,159 473,022 367,002
General and administrative 324,868 317,250 684,406 652,981
Total operating expenses 602,805 574,009 1,232,774 1,095,267
Loss from operations (602,805) (574,009) (1,232,774) (1,095,267)
Other expense:        
Modification of warrants (208,556) (224,362)
Interest expense 569 491 2,081 1,630
Interest expense - debt discount 116,737 297,141 159,944 1,088,849
Interest expense - original issuance costs 142,272 60,039 225,672 102,776
Total other expense 259,578 149,115 387,697 968,893
Loss before income taxes (862,383) (723,124) (1,620,471) (2,064,160)
Income taxes
Net loss $ (862,383) $ (723,124) $ (1,620,471) $ (2,064,160)
Net loss per share, basic $ (0.70) $ (0.67) $ (1.31) $ (2.02)
Net loss per share, diluted $ (0.70) $ (0.67) $ (1.31) $ (2.02)
Weighted average number of shares outstanding, basic 1,238,085 1,083,277 1,234,241 1,022,795
Weighted average number of shares outstanding, diluted 1,238,085 1,083,277 1,234,241 1,022,795